A Study of Belzutifan in Adolescent Participants With Solid Tumors (MK-9999-01E/LIGHTBEAM-U01)
Conditions : Malignant Neoplasm Interventions : Drug: Belzutifan Sponsors : Merck Sharp & Dohme LLC Not yet recruiting
Read the full article3d agoen
You might also wanna read
Preadmission GLP-1 Receptor Agonist Plus SGLT2 Inhibitor Use and Early Outcomes After Pneumonia Hospitalization in Adults With Type 2 Diabetes
clinicaltrials.gov·just now
Vaccine-preventable diseases re-emerge globally in post-elimination era, researchers warn
plos.io·2h ago
What is clinical metagenomics? A scientist explains its potential for diagnosing infections
quadram.ac.uk·2h agoPerineural Invasion Linked to Poorer ICC Survival Outcomes
emjreviews.com·2h ago
STAT+: MDCalc is scoring the clinical calculators used by millions of doctors
STAT·3h ago
Why affirming trans identities can be critical for suicide prevention counseling
STAT·3h ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.